Bleomycin, etoposide, and cisplatin for three cycles compared with etoposide and cisplatin for four cycles in good-risk germ cell tumors: Is there a preferred regimen? - Reply Journal Article

  

Authors:	Kondagunta, G. V.; Motzer, R. J.; Bosl, G. J.; Sheinfeld, J.
Article Title:	Bleomycin, etoposide, and cisplatin for three cycles compared with etoposide and cisplatin for four cycles in good-risk germ cell tumors: Is there a preferred regimen? - Reply
Keywords:	cancer survival; clinical trial; cisplatin; cancer risk; drug dose reduction; drug efficacy; hypertension; lymph node dissection; letter; lung toxicity; etoposide; morbidity; cancer mortality; cardiovascular disease; heart infarction; bleomycin; teratoma; germ cell tumor; drug tolerance; raynaud phenomenon
Journal Title:	Journal of Clinical Oncology
Volume:	24
Issue:	16
ISSN:	0732-183X
Publisher:	American Society of Clinical Oncology
Date Published:	2006-06-01
Start Page:	2598
End Page:	2599
Language:	English
DOI:	10.1200/jco.2006.05.6523
PROVIDER:	scopus
DOI/URL:	http://www.scopus.com/inward/record.url?eid=2-s2.0-34247348704&partnerID=40&md5=47a733e4c12ae2e7daa187a964e317f3
Notes:	--- - "Export Date: 4 June 2012" - "CODEN: JCOND" - "Source: Scopus"

https://synapse.mskcc.org/synapse/works/has_related_data_chk/27541